Indication
Pneumonic
2 clinical trials
6 products
Clinical trial
Phase 2, Randomized, Active-Controlled, Observer-Blinded, Multicenter Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of AgeStatus: Active (not recruiting), Estimated PCD: 2023-10-03
Product
rF1VProduct
rF1V vaccineClinical trial
An Open-label, Randomised, Non-inferiority Trial of the Efficacy and Safety of Ciprofloxacin Versus an Aminoglycoside Followed by Ciprofloxacin in the Treatment of Bubonic PlagueStatus: Recruiting, Estimated PCD: 2024-04-30
Product
CiprofloxacinProduct
StreptomycinProduct
Gentamicin